aTyr Pharma Inc. (LIFE)
NASDAQ: LIFE
· Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM
aTyr Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 41.59M | -18.8M | -15.49M | -15.49M | -14.76M | -11.34M | -12.34M | -11.95M | -7.52M | -13.24M | -12.42M | -12.15M | -8.56M | -7.67M | -10.39M | -7.16M |
Depreciation & Amortization | -2.17M | 364K | n/a | 770K | 407K | 993K | 586K | 755K | 697K | 414K | 286K | 298K | 320K | 329K | 358K | 297K |
Stock-Based Compensation | -2.06M | 820K | 740K | 740K | 659K | 664K | 658K | 619K | 605K | 615K | 517K | 417K | 414K | 442K | 398K | 360K |
Other Working Capital | 5.98M | 7.23M | n/a | -7.82M | 589K | 1.25M | -726K | 1.58M | -10.86M | -2.02M | -588K | n/a | -535K | n/a | n/a | n/a |
Other Non-Cash Items | -8.18M | -7.54M | n/a | -1.03M | -2.34M | 11.33M | 11.33M | -419K | -29K | 125K | 197K | 148K | 229K | 37K | 55K | 51K |
Deferred Income Tax | 10.85M | -1.46M | n/a | n/a | 1.46M | -12.31M | -12.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.97M | 4.07M | n/a | -7.59M | 3.52M | 1.1M | -17K | 10.41M | -4.12M | -190K | 2.3M | 1.17M | -488K | -4.61M | 1.89M | 620K |
Operating Cash Flow | 43M | -22.55M | n/a | -22.38M | -11.06M | -9.56M | -12.01M | -590K | -10.37M | -12.28M | -9.12M | -10.12M | -8.09M | -11.47M | -7.69M | -5.83M |
Capital Expenditures | 591K | -6K | n/a | -17K | -17K | -557K | -2.4M | -1.25M | -1.12M | -426K | -53K | -43K | -18K | -61K | -96K | -17K |
Cash Acquisitions | 22.77M | 17.84M | n/a | n/a | -17.84M | -4.94M | 15K | 36.93M | 533K | 10K | -10.02M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 59.61M | -12.03M | n/a | -21.34M | -9.66M | -28.61M | -22.48M | -46.23M | -24.99M | -5.95M | -11.18M | n/a | -57.7M | -28.79M | -14.35M | -25.68M |
Sales Maturities Of Investments | -81.05M | 16.74M | n/a | 20M | 27.5M | 33.55M | 20.7M | 9.3M | 28.11M | 27.01M | 21.2M | 14.5M | 8.31M | 14M | 10.47M | 2.3M |
Other Investing Acitivies | -5.54M | -15.68M | n/a | n/a | 17.84M | 4.94M | -1.76M | -36.93M | -533K | 21.07M | 10.02M | 169K | 50K | n/a | n/a | n/a |
Investing Cash Flow | -3.61M | 6.86M | n/a | -1.36M | 17.82M | 4.38M | -4.16M | -38.17M | 2M | 20.65M | 9.97M | 14.63M | -49.35M | -14.85M | -3.97M | -23.39M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -40K | 64K | 39K | n/a | -25K | 65K | 65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 40.59M | 78K | n/a | 7.73M | 6.03M | 2.68M | 8.02M | 49.5M | 918K | 3.01M | 39K | 1.48M | 28K | 83.87M | 1.27M | 24.86M |
Financial Cash Flow | 23.42M | 7.26M | n/a | 7.73M | 6.03M | 2.68M | 8.02M | 49.5M | 918K | 3.01M | 39K | 1.48M | 28K | 83.87M | 1.27M | 24.86M |
Net Cash Flow | n/a | 7.58M | n/a | -16.01M | 12.76M | -2.49M | -4.96M | 7.54M | -7.45M | 11.38M | 893K | 5.99M | -57.41M | 57.55M | -10.39M | -4.37M |
Free Cash Flow | 43.59M | -22.55M | n/a | -22.4M | -11.08M | -10.12M | -14.4M | -1.84M | -11.49M | -12.71M | -9.17M | -10.16M | -8.1M | -11.53M | -7.79M | -5.84M |